Status:
RECRUITING
Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy
Lead Sponsor:
Rebecka Ohm
Conditions:
Facial Paralysis
Facial Palsy
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate neurotomy as an alternative treatment to Botox injections for severe synkinesis following peripheral facial palsy
Detailed Description
Patients with severe synkinesis treated at Karolinska University Hospital with Botox injections with unsatisfying results are invited to participate in this study aiming to evaluate surgical neurotomy...
Eligibility Criteria
Inclusion
- Synkinesis following peripheral facial palsy
- Sunnybrook score \<61
- Botox injections at least 3 times a year
- Have received at least 3 Botox injections
- Botox injections not satisfying treatment
- Read and signed written consent
Exclusion
- Synkinesis since less than 2 years
- Contractures in facial muscles
- Other planned surgery in the face during study period
- Smoking
- Uncontrolled hypertension
- Diabetes mellitus
- Pregnancy or breast feeding
- Severe systemic disease (ASA 3-4)
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT05191719
Start Date
February 1 2022
End Date
February 1 2026
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital/Karolinska Institute
Stockholm, Sweden